News and Events

Hatchtech obtains allowance of claims in United States

1/08/2010 | Press Releases

Hatchtech Pty Ltd announced today that it had one of its key patents allowed in the United States. The patent protects Hatchtech’s lead compound for use in controlling a range of pests and parasites including head lice. ‘This patent represents a very important milestone for the company’ said Hatchtech’s founder and Chief Scientific Officer, Dr Vern Bowles. ‘The US is a key target market for our head lice product De Ovo™ he said.

No PDF Available